Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Safety of selective serotonin reuptake inhibitor use prior to coronary artery bypass grafting.

Xiong GL, Jiang W, Clare RM, Shaw LK, Smith PK, O'Connor CM, Ranga K, Krishnan R, Kristin Newby L.

Clin Cardiol. 2010 Jun;33(6):E94-8. doi: 10.1002/clc.20621.

2.

Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting.

Kim DH, Daskalakis C, Whellan DJ, Whitman IR, Hohmann S, Medvedev S, Kraft WK.

Am J Cardiol. 2009 May 15;103(10):1391-5. doi: 10.1016/j.amjcard.2009.01.348. Epub 2009 Apr 1.

PMID:
19427434
3.

Effect of selective serotonin reuptake inhibitors on requirement for allogeneic red blood cell transfusion following coronary artery bypass surgery.

Andreasen JJ, Riis A, Hjortdal VE, Jørgensen J, Sørensen HT, Johnsen SP.

Am J Cardiovasc Drugs. 2006;6(4):243-50.

PMID:
16913825
4.

Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting.

Xiong GL, Jiang W, Clare R, Shaw LK, Smith PK, Mahaffey KW, O'Connor CM, Krishnan KR, Newby LK.

Am J Cardiol. 2006 Jul 1;98(1):42-7. Epub 2006 May 5.

PMID:
16784918
5.

Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery.

Tully PJ, Cardinal T, Bennetts JS, Baker RA.

Heart Lung Circ. 2012 Apr;21(4):206-14. doi: 10.1016/j.hlc.2011.12.002. Epub 2012 Jan 28.

PMID:
22285303
6.

Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery.

Tuman KJ, McCarthy RJ, O'Connor CJ, McCarthy WE, Ivankovich AD.

Anesth Analg. 1996 Dec;83(6):1178-84.

PMID:
8942582
7.

The effect of preoperative clopidogrel on bleeding after coronary artery bypass surgery.

Kang W, Theman TE, Reed JF 3rd, Stoltzfus J, Weger N.

J Surg Educ. 2007 Mar-Apr;64(2):88-92.

PMID:
17462208
8.

Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?

Kapetanakis EI, Medlam DA, Boyce SW, Haile E, Hill PC, Dullum MK, Bafi AS, Petro KR, Corso PJ.

Eur Heart J. 2005 Mar;26(6):576-83. Epub 2005 Feb 21.

9.

Effect of clopidogrel on bleeding after coronary artery bypass surgery.

Yende S, Wunderink RG.

Crit Care Med. 2001 Dec;29(12):2271-5.

PMID:
11801823
10.

Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery.

Wang X, Zheng Z, Ao H, Zhang S, Wang Y, Zhang H, Hu S.

Ann Thorac Surg. 2010 May;89(5):1489-95. doi: 10.1016/j.athoracsur.2010.02.006.

PMID:
20417766
11.

Effects of a waiting period after clopidogrel treatment before performing coronary artery bypass grafting.

Reichert MG, Robinson AH, Travis JA, Hammon JW, Kon ND, Kincaid EH.

Pharmacotherapy. 2008 Feb;28(2):151-5. doi: 10.1592/phco.28.2.151.

PMID:
18225962
12.

Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis.

Berger JS, Frye CB, Harshaw Q, Edwards FH, Steinhubl SR, Becker RC.

J Am Coll Cardiol. 2008 Nov 18;52(21):1693-701. doi: 10.1016/j.jacc.2008.08.031.

13.

Preoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgery.

Argalious M, Xu M, Sun Z, Smedira N, Koch CG.

Anesth Analg. 2010 Aug;111(2):324-30. doi: 10.1213/ANE.0b013e3181d8a078. Epub 2010 Apr 7.

PMID:
20375302
14.

Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease.

Mack MJ, Pfister A, Bachand D, Emery R, Magee MJ, Connolly M, Subramanian V.

J Thorac Cardiovasc Surg. 2004 Jan;127(1):167-73.

15.

Preoperative platelet inhibition with ASA does not influence postoperative blood loss following coronary artery bypass grafting.

Gulbins H, Malkoc A, Ennker IC, Ennker J.

Thorac Cardiovasc Surg. 2009 Feb;57(1):18-21. doi: 10.1055/s-2008-1038791. Epub 2009 Jan 23.

PMID:
19169991
16.

Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group.

Dacey LJ, Munoz JJ, Baribeau YR, Johnson ER, Lahey SJ, Leavitt BJ, Quinn RD, Nugent WC, Birkmeyer JD, O'Connor GT.

Arch Surg. 1998 Apr;133(4):442-7.

PMID:
9565127
17.

Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study.

Gärtner R, Cronin-Fenton D, Hundborg HH, Pedersen L, Lash TL, Sørensen HT, Kroman N.

BMC Surg. 2010 Jan 24;10:3. doi: 10.1186/1471-2482-10-3.

18.

Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery.

Kuduvalli M, Oo AY, Newall N, Grayson AD, Jackson M, Desmond MJ, Fabri BM, Rashid A.

Eur J Cardiothorac Surg. 2005 Apr;27(4):592-8.

PMID:
15784356
19.

Propensity case-matched analysis of off-pump coronary artery bypass grafting in patients with atheromatous aortic disease.

Sharony R, Grossi EA, Saunders PC, Galloway AC, Applebaum R, Ribakove GH, Culliford AT, Kanchuger M, Kronzon I, Colvin SB.

J Thorac Cardiovasc Surg. 2004 Feb;127(2):406-13.

20.

Leukoreduction program for red blood cell transfusions in coronary surgery: association with reduced acute kidney injury and in-hospital mortality.

Romano G, Mastroianni C, Bancone C, Della Corte A, Galdieri N, Nappi G, De Santo LS.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):188-95. doi: 10.1016/j.jtcvs.2010.03.022. Epub 2010 Apr 22.

Items per page

Supplemental Content

Write to the Help Desk